Despite despatching vaccines to curb the expansion of the deadly coronavirus in various countries, India struggles to fulfil the vaccination for its indigenous requirements. When it has been running a vast immunisation programme to immunise the people, it surely needs to expend plenty of extra momentum to address its huge goal within the country’s remotest areas.
It is not certain whether the country has enough vaccines and state capacity to intensify its huge vaccination drive. Maharashtra health minister Rajesh Tope has raised a demand for 40 lakh doses every week from the Centre amidst a shortage of doses. Officials have complained that the Centre is not replenishing stocks regularly.
However, it can’t be completely neglected that the large adult vaccination programme that runs against a virulent pathogen like SARS-CoV-2, virus spurring Covid-19, affirms extraordinary complications all over the inhabited territories. Yet, there hovers a sense of unfailing hope.
According to a verified news report, India produces 60% of the world’s vaccines. More than this, it happens to also be home to half a dozen important vaccine manufacturing companies. Even the world’s largest manufacturer exists here (Serum Institute of India).
Those having a straight watchfulness on the significant vaccination drive feel nothing odd in appreciating the ongoing drive. They exhibit their ample courage to point out that India has a big obligation amid continuing the drive.
Without a doubt, the most important concern that is said to be causing wide anxiety among the specialists or expert was nothing but providing the jab to young people. Many have been pondering whether our country has enough stock of doses to speed up the drive and ably expand its range to young people as they are also falling prey to this unruly infection. Their timely vaccination remains vital given the second wave of the coronavirus.
Some are bound to gape whether India followed the ethical approach by delivering millions of doses out of the country as part of its intensely publicised “vaccine diplomacy”.
Exports were questioned as the policy has come under question. Some opposition parties have demanded curbs on exports till the entire population is immunised.
By the middle of March, India had exported over twice the number of doses it had conducted at home. As has been reported, millions of doses were given as aids to neighbourly and friendly countries. Those were either shipped out under commercial contracts or the UNs Covax programme.
The government’s “Vaccine Maitri” outreach seemed well on track. But with the second wave of Covid-19, it started hitting hard. Therefore, the policy has come under overwhelming querying.